Mittal, Maria Luisa
Vashishtha, Devesh
Sun, Shelly
Jain, Sonia
Cuevas-Mota, Jazmine
Garfein, Richard
Strathdee, Steffanie A.
Werb, Dan
Funding for this research was provided by:
National Institute on Drug Abuse (T32DA023356)
National Institute on Drug Abuse (R01DA031074)
National Institute on Drug Abuse (R37DA019829)
National Institute on Drug Abuse (DP2-DA040256-01)
Fogarty International Center (D43TW008633)
Fogarty International Center (R25TW009343)
National Institute of Allergy and Infectious Diseases (P30AI36214)
National Institutes of Health (1TL1TR001443)
Canadian Institutes of Health Research (New Investigator Award)
Article History
Received: 16 March 2017
Accepted: 26 September 2017
First Online: 3 October 2017
Ethics approval and consent to participate
: The study was approved by the research ethics board at the University of California San Diego Human Research Protection Program. All participants provided written informed consent for study participation.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.